ANI Pharmaceuticals (BSFA) Q1 2026 Earnings Report
DE:BSFA Q1 2026 EPS Results
- Actual EPS
- EUR 1.84
- Consensus EPS
- EUR 1.16
- Beat/Miss
- Beat by +EUR 0.67
- One Year Ago EPS
- EUR 1.52
DE:BSFA Q1 2026 Revenue Results
- Actual Revenue
- EUR 212.62M
- Expected Revenue
- EUR 185.91M
- Beat/Miss
- Beat by +EUR 26.71M
- YoY Revenue Growth
- +20.46%
Earnings Announcement Details
- Quarter
- Q1 2026
- Date
- 05/08/2026
- Time
- Before Open
- Conference Call
- Friday, May 8, 2026
DE:BSFA Upcoming Earnings
ANI Pharmaceuticals's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
Q1 2026 Earnings Call Audio
DE:BSFA Q1 2026 Earnings Call
0:00 / 0:00
Q1 2026 Earnings Slide Deck
Q1 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:BSFA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 05, 2026 | 2026 (Q3) | 1.95- | 1.83 | ― | ― |
| Aug 07, 2026 | 2026 (Q2) | 1.831.98 | 1.61 | 22.78% (+0.37) | |
| May 08, 2026 | 2026 (Q1) | 1.161.84 | 1.52 | 20.59% (+0.31) | |
| Mar 03, 2026 | 2025 (Q4) | 1.782.09 | 1.46 | 42.94% (+0.63) | |
| Nov 10, 2025 | 2025 (Q3) | 1.581.83 | 1.2 | 52.24% (+0.63) | |
| Aug 08, 2025 | 2025 (Q2) | 1.261.61 | 0.91 | 76.47% (+0.70) | |
| May 09, 2025 | 2025 (Q1) | 1.241.52 | 1.08 | 40.50% (+0.44) | |
| Feb 28, 2025 | 2024 (Q4) | 1.281.46 | 0.9 | 63.00% (+0.56) | |
| Nov 08, 2024 | 2024 (Q3) | 0.971.20 | 1.14 | 5.51% (+0.06) | |
| Aug 06, 2024 | 2024 (Q2) | 0.850.91 | 1.15 | -20.31% (-0.23) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
